(-0.02%) 5 212.75 points
(-0.01%) 39 022 points
(-0.03%) 18 195 points
(-0.52%) $77.97
(0.32%) $2.21
(0.08%) $2 326.00
(0.20%) $27.60
(-0.15%) $986.90
(0.12%) $0.931
(0.37%) $10.94
(0.17%) $0.801
(0.04%) $91.47
Live Chart Being Loaded With Signals
Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China...
Stats | |
---|---|
आज की मात्रा | 7 000.00 |
औसत मात्रा | 751 308 |
बाजार मूल्य | 1.02B |
EPS | HKD0 ( 2023-08-23 ) |
अगली कमाई की तारीख | ( HKD0 ) 2024-05-17 |
Last Dividend | HKD0.0300 ( 2023-05-23 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 5.71 |
ATR14 | HKD0.0130 (1.08%) |
Zhongzhi Pharmaceutical सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Zhongzhi Pharmaceutical वित्तीय
Annual | 2023 |
राजस्व: | HKD2.05B |
सकल लाभ: | HKD1.22B (59.43 %) |
EPS: | HKD0.190 |
FY | 2023 |
राजस्व: | HKD2.05B |
सकल लाभ: | HKD1.22B (59.43 %) |
EPS: | HKD0.190 |
FY | 2022 |
राजस्व: | HKD1.83B |
सकल लाभ: | HKD1.07B (58.45 %) |
EPS: | HKD0.130 |
FY | 2021 |
राजस्व: | HKD1.75B |
सकल लाभ: | HKD1.06B (60.78 %) |
EPS: | HKD0.0630 |
Financial Reports:
No articles found.
Zhongzhi Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.0300 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0350 | 2016-05-17 |
Last Dividend | HKD0.0300 | 2023-05-23 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 12 | -- |
Total Paid Out | HKD0.282 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.68 | -- |
Div. Sustainability Score | 9.95 | |
Div.Growth Potential Score | 3.81 | |
Div. Directional Score | 6.88 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
2360.HK | Ex Dividend Knight | 2023-10-03 | Annually | 0 | 0.00% | |
1345.HK | Ex Dividend Junior | 2023-10-04 | Semi-Annually | 0 | 0.00% | |
0386.HK | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
6677.HK | Ex Dividend Junior | 2023-06-01 | Annually | 0 | 0.00% | |
1897.HK | Ex Dividend Knight | 2023-07-05 | Semi-Annually | 0 | 0.00% | |
0921.HK | Ex Dividend Junior | 2023-07-10 | Sporadic | 0 | 0.00% | |
0038.HK | Ex Dividend Knight | 2023-06-08 | Sporadic | 0 | 0.00% | |
2880.HK | Ex Dividend Junior | 2023-06-20 | Annually | 0 | 0.00% | |
1469.HK | Ex Dividend Knight | 2023-08-29 | Semi-Annually | 0 | 0.00% | |
0538.HK | Ex Dividend Junior | 2023-06-12 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0794 | 1.500 | 8.41 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0908 | 1.200 | 6.97 | 8.37 | [0 - 0.3] |
returnOnEquityTTM | 0.154 | 1.500 | 9.40 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.714 | -1.000 | 2.86 | -2.86 | [0 - 1] |
currentRatioTTM | 1.436 | 0.800 | 7.82 | 6.25 | [1 - 3] |
quickRatioTTM | 0.813 | 0.800 | 9.93 | 7.94 | [0.8 - 2.5] |
cashRatioTTM | 0.270 | 1.500 | 9.61 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.126 | -1.500 | 7.91 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.113 | 2.00 | 9.96 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | -0.0753 | 2.00 | -0.0376 | -0.0753 | [0 - 20] |
debtEquityRatioTTM | 0.215 | -1.500 | 9.14 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.593 | 1.000 | 3.46 | 3.46 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0800 | 1.000 | -0.401 | -0.401 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.451 | 1.000 | 8.61 | 8.61 | [0.2 - 2] |
assetTurnoverTTM | 1.143 | 0.800 | 5.71 | 4.57 | [0.5 - 2] |
Total Score | 9.95 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 6.06 | 1.000 | 9.49 | 0 | [1 - 100] |
returnOnEquityTTM | 0.154 | 2.50 | 9.62 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.0753 | 2.00 | -0.0251 | -0.0753 | [0 - 30] |
dividendYielPercentageTTM | 8.89 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.113 | 2.00 | 9.96 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.714 | 1.500 | 2.86 | -2.86 | [0 - 1] |
pegRatioTTM | 0.0605 | 1.500 | -2.93 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0495 | 1.000 | -1.262 | 0 | [0.1 - 0.5] |
Total Score | 3.81 |
Zhongzhi Pharmaceutical
Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company operates through three segments: Pharmaceutical Manufacturing, Operation of Chain Pharmacies, and Operation of On-Line Pharmacies. It provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brands. The company is also manufacture and sale of food and Chinese herbs; property management; and pharmaceutical drugs, as well as offers detection and testing services. As of December 31, 2021, it operated 398 self-operated chain pharmacies, including 361 medical insurance designated pharmacies located in Zhongshan in the Guangdong Province under the Zeus brand. The company was founded in 1993 and is headquartered in Zhongshan, the People's Republic of China. Zhongzhi Pharmaceutical Holdings Limited is a subsidiary of Crystal Talent Investment Group Limited.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं